{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:09:31Z","timestamp":1788966571531,"version":"build-2803163510"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10787-026-02354-8","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:16:00Z","timestamp":1786349760000},"page":"5901-5917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From xanthine oxidase inhibition to inflammasome regulation: exploring the potential role of allopurinol in TXNIP\u2013NLRP3 signaling and pyroptosis in diabetes"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-9649","authenticated-orcid":false,"given":"Faiz","family":"Qamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3068-8959","authenticated-orcid":false,"given":"Ramsha","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4102-5797","authenticated-orcid":false,"given":"Mohd","family":"Vaseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0628-6572","authenticated-orcid":false,"given":"Tufail","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-9191","authenticated-orcid":false,"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-6626","authenticated-orcid":false,"given":"Manju","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2354_CR1","doi-asserted-by":"publisher","first-page":"115734","DOI":"10.1016\/J.BIOPHA.2023.115734","volume":"168","author":"SA Antar","year":"2023","unstructured":"Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, Roh EJ, Elkamhawy A, Al-Karmalawy AA (2023) Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother 168:115734. https:\/\/doi.org\/10.1016\/J.BIOPHA.2023.115734","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2354_CR2","doi-asserted-by":"publisher","first-page":"119573","DOI":"10.1016\/J.BBAMCR.2023.119573","volume":"1871","author":"D Averill-Bates","year":"2024","unstructured":"Averill-Bates D (2024) Reactive oxygen species and cell signaling. Review. Biochimica et Biophysica Acta (BBA) Mol Cell Res 1871(2):119573. https:\/\/doi.org\/10.1016\/J.BBAMCR.2023.119573","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Cell Res"},{"key":"2354_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX11020318","author":"AE B\u0103dil\u0103","year":"2022","unstructured":"B\u0103dil\u0103 AE, R\u0103dulescu DM, Ilie A, Niculescu AG, Grumezescu AM, R\u0103dulescu AR (2022) bone regeneration and oxidative stress: an updated overview. Antioxidants. https:\/\/doi.org\/10.3390\/ANTIOX11020318","journal-title":"Antioxidants"},{"issue":"7","key":"2354_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","volume":"26","author":"Y Bai","year":"2025","unstructured":"Bai Y, Pan Y, Liu X (2025) Mechanistic insights into gasdermin-mediated pyroptosis. Nat Rev Mol Cell Biol 26(7):501\u2013521. https:\/\/doi.org\/10.1038\/s41580-025-00837-0","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2354_CR5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS (2021) Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol 18(5):1106\u20131121. https:\/\/doi.org\/10.1038\/s41423-020-00630-3","journal-title":"Cell Mol Immunol"},{"key":"2354_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/J.FREERADBIOMED.2022.03.019","volume":"184","author":"JS Bhatti","year":"2022","unstructured":"Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, Kumar S, Bhatti GK, Reddy PH (2022) Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radic Biol Med 184:114\u2013134. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2022.03.019","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2354_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41413-022-00219-8","volume":"10","author":"S Bolamperti","year":"2022","unstructured":"Bolamperti S, Villa I, Rubinacci A (2022) Bone remodeling: an operational process ensuring survival and bone mechanical competence. Bone Res 10(1):48. https:\/\/doi.org\/10.1038\/s41413-022-00219-8","journal-title":"Bone Res"},{"key":"2354_CR8","doi-asserted-by":"publisher","first-page":"101882","DOI":"10.1016\/J.REDOX.2021.101882","volume":"41","author":"M Bortolotti","year":"2021","unstructured":"Bortolotti M, Polito L, Battelli MG, Bolognesi A (2021) Xanthine oxidoreductase: one enzyme for multiple physiological tasks. Redox Biol 41:101882. https:\/\/doi.org\/10.1016\/J.REDOX.2021.101882","journal-title":"Redox Biol"},{"issue":"4","key":"2354_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/ANTIOX6040090","volume":"6","author":"D Burtenshaw","year":"2017","unstructured":"Burtenshaw D, Hakimjavadi R, Redmond EM, Cahill PA (2017) Nox, reactive oxygen species and regulation of vascular cell fate. Antioxidants (Basel) 6(4):90. https:\/\/doi.org\/10.3390\/ANTIOX6040090","journal-title":"Antioxidants (Basel)"},{"key":"2354_CR10","doi-asserted-by":"publisher","first-page":"1761121","DOI":"10.3389\/FIMMU.2026.1761121\/FULL","volume":"17","author":"D Cao","year":"2026","unstructured":"Cao D, Pu H, Yuan X, Li Z, Yu X, Shi X (2026) The interplay between NLRP3 inflammasome and metabolic signals in gouty arthritis. Front Immunol 17:1761121. https:\/\/doi.org\/10.3389\/FIMMU.2026.1761121\/FULL","journal-title":"Front Immunol"},{"key":"2354_CR11","doi-asserted-by":"publisher","first-page":"111702","DOI":"10.1016\/J.CELLSIG.2025.111702","volume":"130","author":"Y Cao","year":"2025","unstructured":"Cao Y, Hu L, Chen R, Chen Y, Liu H, Wei J (2025) Unfolded protein response-activated NLRP3 inflammasome contributes to pyroptotic and apoptotic podocyte injury in diabetic kidney disease via the CHOP-TXNIP axis. Cell Signal 130:111702. https:\/\/doi.org\/10.1016\/J.CELLSIG.2025.111702","journal-title":"Cell Signal"},{"issue":"1","key":"2354_CR12","doi-asserted-by":"publisher","first-page":"23605","DOI":"10.1038\/s41598-025-05818-z","volume":"15","author":"E Cecerska-Hery\u0107","year":"2025","unstructured":"Cecerska-Hery\u0107 E, Engwert W, Micha\u0142\u00f3w J, Marciniak J, Birger R, Serwin N, Hery\u0107 R, Polikowska A, Goszka M, Wojciuk B, Wi\u015bniewska M, Do\u0142\u0119gowska B (2025) Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications. Sci Rep 15(1):23605. https:\/\/doi.org\/10.1038\/s41598-025-05818-z","journal-title":"Sci Rep"},{"key":"2354_CR13","doi-asserted-by":"publisher","first-page":"107776","DOI":"10.1016\/J.PHRS.2025.107776","volume":"216","author":"J Chen","year":"2025","unstructured":"Chen J, Fei S, Chan LWC, Gan X, Shao B, Jiang H, Li S, Kuang P, Liu X, Yang S (2025a) Inflammatory signaling pathways in pancreatic \u03b2-cell: new insights into type 2 diabetes pathogenesis. Pharmacol Res 216:107776. https:\/\/doi.org\/10.1016\/J.PHRS.2025.107776","journal-title":"Pharmacol Res"},{"issue":"4","key":"2354_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/S10753-021-01439-6","volume":"44","author":"M Chen","year":"2021","unstructured":"Chen M, Ye X, He X, Ouyang D (2021) The signaling pathways regulating NLRP3 inflammasome activation. Inflammation 44(4):1229\u20131245. https:\/\/doi.org\/10.1007\/S10753-021-01439-6","journal-title":"Inflammation"},{"issue":"1","key":"2354_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/S41392-025-02264-1","volume":"10","author":"R Chen","year":"2025","unstructured":"Chen R, Zou J, Chen J, Zhong X, Kang R, Tang D (2025b) Pattern recognition receptors: function, regulation and therapeutic potential. Signal Transduct Target Ther 10(1):216. https:\/\/doi.org\/10.1038\/S41392-025-02264-1","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"2354_CR16","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","volume":"55","author":"EH Choi","year":"2023","unstructured":"Choi EH, Park SJ (2023) TXNIP: a key protein in the cellular stress response pathway and a potential therapeutic target. Exp Mol Med 55(7):1348\u20131356. https:\/\/doi.org\/10.1038\/s12276-023-01019-8","journal-title":"Exp Mol Med"},{"issue":"4","key":"2354_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1089\/ARS.2022.0022","volume":"38","author":"S Dagdeviren","year":"2023","unstructured":"Dagdeviren S, Lee RT, Wu N (2023) Physiological and pathophysiological roles of thioredoxin interacting protein: a perspective on redox inflammation and metabolism. Antioxid Redox Signal 38(4):442\u2013460. https:\/\/doi.org\/10.1089\/ARS.2022.0022","journal-title":"Antioxid Redox Signal"},{"key":"2354_CR18","doi-asserted-by":"publisher","first-page":"102033","DOI":"10.1016\/J.REDOX.2021.102033","volume":"45","author":"X Dai","year":"2021","unstructured":"Dai X, Liao R, Liu C, Liu S, Huang H, Liu J, Jin T, Guo H, Zheng Z, Xia M, Ling W, Xiao Y (2021) Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Redox Biol 45:102033. https:\/\/doi.org\/10.1016\/J.REDOX.2021.102033","journal-title":"Redox Biol"},{"key":"2354_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41569-026-01274-y","volume":"2026","author":"MJ De Blasio","year":"2026","unstructured":"De Blasio MJ, Ritchie RH (2026) Inflammatory signalling in diabetic cardiomyopathy: molecular mechanisms and potential therapeutic strategies. Nat Rev Cardiol 2026:1\u201315. https:\/\/doi.org\/10.1038\/s41569-026-01274-y","journal-title":"Nat Rev Cardiol"},{"issue":"10\u201312","key":"2354_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1089\/ARS.2020.8257","volume":"36","author":"A Dominic","year":"2022","unstructured":"Dominic A, Le NT, Takahashi M (2022) Loop between NLRP3 inflammasome and reactive oxygen species. Journalssagepubcom 36(10\u201312):784\u2013796. https:\/\/doi.org\/10.1089\/ARS.2020.8257","journal-title":"Journalssagepubcom"},{"key":"2354_CR21","doi-asserted-by":"publisher","first-page":"114620","DOI":"10.1016\/J.INTIMP.2025.114620","volume":"155","author":"H Duan","year":"2025","unstructured":"Duan H, Zhang R, Asikaer A, Pan L, Wang S, Huang K, Lou D, Wang Y, Lin Z, Shen Y (2025) Nicotinamide mononucleotide ameliorates hypertriglyceridemia pancreatitis via NAD+\/SIRT1-mediated TXNIP suppression and NOTCH pathway for accelerated repair-associated processes. Int Immunopharmacol 155:114620. https:\/\/doi.org\/10.1016\/J.INTIMP.2025.114620","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2354_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","volume":"9","author":"XP Duan","year":"2024","unstructured":"Duan XP, Qin BD, Jiao XD, Liu K, Wang Z, Zang YS (2024) New clinical trial design in precision medicine: discovery, development and direction. Signal Transduct Target Ther 9(1):57. https:\/\/doi.org\/10.1038\/s41392-024-01760-0","journal-title":"Signal Transduct Target Ther"},{"key":"2354_CR23","doi-asserted-by":"publisher","first-page":"1558041","DOI":"10.3389\/FIMMU.2025.1558041\/FULL","volume":"16","author":"J Feng","year":"2025","unstructured":"Feng J, MengHuan L, TingTing Y, XueJie Y, HaiNing G (2025) Research progress on AMPK in the pathogenesis and treatment of MASLD. Front Immunol 16:1558041. https:\/\/doi.org\/10.3389\/FIMMU.2025.1558041\/FULL","journal-title":"Front Immunol"},{"issue":"3","key":"2354_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/WOUND.2016.0724","volume":"7","author":"ML Fernandez","year":"2018","unstructured":"Fernandez ML, Stupar D, Croll T, Leavesley D, Upton Z (2018) Xanthine oxidoreductase: A novel therapeutic target for the treatment of chronic wounds? Adv Wound Care 7(3):95. https:\/\/doi.org\/10.1089\/WOUND.2016.0724","journal-title":"Adv Wound Care"},{"issue":"MAY","key":"2354_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/FENDO.2019.00291\/FULL","volume":"10","author":"G Filhoulaud","year":"2019","unstructured":"Filhoulaud G, Benhamed F, Pagesy P, Bonner C, Fardini Y, Ilias A, Movassat J, Burnol AF, Guilmeau S, Kerr-Conte J, Pattou F, Issad T, Postic C (2019) O-GlcNAcylation links TXNIP to inflammasome activation in pancreatic \u03b2 cells. Front Endocrinol 10(MAY):291. https:\/\/doi.org\/10.3389\/FENDO.2019.00291\/FULL","journal-title":"Front Endocrinol"},{"key":"2354_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/J.BIOPHA.2018.07.157","volume":"107","author":"B Giri","year":"2018","unstructured":"Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK (2018) Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed Pharmacother 107:306\u2013328. https:\/\/doi.org\/10.1016\/J.BIOPHA.2018.07.157","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2354_CR27","doi-asserted-by":"publisher","first-page":"101940","DOI":"10.1016\/J.GENDIS.2025.101940","volume":"13","author":"Q Gong","year":"2026","unstructured":"Gong Q, Huang Y, Liu F, Zhou T, Huang W, Xu Y (2026) Trained immunity: new insights into pathogenesis and therapeutic targets in diabetes and diabetic complications. Genes Dis 13(5):101940. https:\/\/doi.org\/10.1016\/J.GENDIS.2025.101940","journal-title":"Genes Dis"},{"key":"2354_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS24119352","author":"P Gonz\u00e1lez","year":"2023","unstructured":"Gonz\u00e1lez P, Lozano P, Ros G, Solano F (2023) Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS24119352","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2354_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41413-023-00257-w","volume":"11","author":"E Hasco\u00ebt","year":"2023","unstructured":"Hasco\u00ebt E, Blanchard F, Blin-Wakkach C, Guicheux J, Lesclous P, Cloitre A (2023) New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis. Bone Res 11(1):26. https:\/\/doi.org\/10.1038\/s41413-023-00257-w","journal-title":"Bone Res"},{"key":"2354_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7423661","author":"J He","year":"2023","unstructured":"He J, Cui J, Shi Y, Wang T, Xin J, Li Y, Shan X, Zhu Z, Gao Y (2023) Astragaloside IV attenuates high-glucose-induced impairment in diabetic nephropathy by increasing klotho expression via the NF-\u03baB\/NLRP3 axis. J Diabetes Res. https:\/\/doi.org\/10.1155\/2023\/7423661","journal-title":"J Diabetes Res"},{"issue":"3","key":"2354_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/EJI.200940185","volume":"40","author":"V Hornung","year":"2010","unstructured":"Hornung V, Latz E (2010) Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol 40(3):620. https:\/\/doi.org\/10.1002\/EJI.200940185","journal-title":"Eur J Immunol"},{"issue":"6","key":"2354_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou Y, Wang Q, Han B, Chen Y, Qiao X, Wang L (2021) CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis 12(6):523. https:\/\/doi.org\/10.1038\/s41419-021-03813-6","journal-title":"Cell Death Dis"},{"issue":"9","key":"2354_CR33","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/S10495-025-02133-W","volume":"30","author":"S Iranpour","year":"2025","unstructured":"Iranpour S, Arif M, Szegezdi E (2025) Disrupting membranes, controlling cell fate: the role of pore-forming proteins in cell death and therapy. Apoptosis 30(9):1961\u20131988. https:\/\/doi.org\/10.1007\/S10495-025-02133-W","journal-title":"Apoptosis"},{"issue":"6","key":"2354_CR34","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/S12325-025-03185-9","volume":"42","author":"K Islam","year":"2025","unstructured":"Islam K, Islam R, Nguyen I, Malik H, Pirzadah H, Shrestha B, Lentz IB, Shekoohi S, Kaye AD (2025) Diabetes mellitus and associated vascular disease: pathogenesis, complications, and evolving treatments. Adv Ther 42(6):2659. https:\/\/doi.org\/10.1007\/S12325-025-03185-9","journal-title":"Adv Ther"},{"issue":"1","key":"2354_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41420-024-01996-3","volume":"10","author":"M Islamuddin","year":"2024","unstructured":"Islamuddin M, Qin X (2024) Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics. Cell Death Discov 10(1):229. https:\/\/doi.org\/10.1038\/s41420-024-01996-3","journal-title":"Cell Death Discov"},{"issue":"5","key":"2354_CR36","doi-asserted-by":"publisher","first-page":"F765","DOI":"10.1152\/AJPRENAL.00236.2020","volume":"319","author":"S Itano","year":"2020","unstructured":"Itano S, Kadoya H, Satoh M, Nakamura T, Murase T, Sasaki T, Kanwar YS, Kashihara N (2020) Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice. Am J Physiol Renal Physiol 319(5):F765. https:\/\/doi.org\/10.1152\/AJPRENAL.00236.2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2354_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/S12035-025-05389-0","volume":"63","author":"R Jain","year":"2025","unstructured":"Jain R, Vora L, Nathiya D, Khatri DK (2025) Nrf2\u2013Keap1 pathway and NLRP3 inflammasome in Parkinson\u2019s disease: mechanistic crosstalk and therapeutic implications. Mol Neurobiol 63(1):91. https:\/\/doi.org\/10.1007\/S12035-025-05389-0","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2354_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/J.JHIP.2026.05.003","volume":"7","author":"D Jaisankar","year":"2026","unstructured":"Jaisankar D, Jayaprakash N (2026) Cannabidiol as a modulator of NLRP3 inflammasome: mechanistic insights and therapeutic potential. J Holist Integr Pharm 7(2):338\u2013349. https:\/\/doi.org\/10.1016\/J.JHIP.2026.05.003","journal-title":"J Holist Integr Pharm"},{"key":"2354_CR39","doi-asserted-by":"publisher","first-page":"1185317","DOI":"10.3389\/FIMMU.2023.1185317","volume":"14","author":"Q Jin","year":"2023","unstructured":"Jin Q, Liu T, Qiao Y, Liu D, Yang L, Mao H, Ma F, Wang Y, Peng L, Zhan Y (2023) Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols. Front Immunol 14:1185317. https:\/\/doi.org\/10.3389\/FIMMU.2023.1185317","journal-title":"Front Immunol"},{"issue":"8","key":"2354_CR40","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s12276-025-01518-w","volume":"57","author":"CW Kang","year":"2025","unstructured":"Kang CW, Nam JH, Oh JH, Wang EK, Lee SH, Shin HJ, Kim Y. Bin, Lee EJ, Lim BK, Fang S, Cho A, Ku CR (2025) Novel mechanism whereby metformin improves glucose homeostasis: TXNIP\u2013GLUT1 axis modulation enhances intestinal glucotonic effects. Exp Mol Med 57(8):1775\u20131788. https:\/\/doi.org\/10.1038\/s12276-025-01518-w","journal-title":"Exp Mol Med"},{"issue":"2","key":"2354_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/S10787-024-01629-2","volume":"33","author":"V Karmakar","year":"2025","unstructured":"Karmakar V, Chain M, Majie A, Ghosh A, Sengupta P, Dutta S, Mazumder PM, Gorain B (2025) Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis. Inflammopharmacology 33(2):461\u2013484. https:\/\/doi.org\/10.1007\/S10787-024-01629-2","journal-title":"Inflammopharmacology"},{"issue":"6","key":"2354_CR42","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/S10741-025-10562-7","volume":"30","author":"R Kaur","year":"2025","unstructured":"Kaur R, Singh S, Sood P, Singh S, Banerjee S, Singh TG (2025) Diabetic cardiomyopathy: mechanistic insights on molecular pathways and emerging therapeutic approaches. Heart Fail Rev 30(6):1443\u20131480. https:\/\/doi.org\/10.1007\/S10741-025-10562-7","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2354_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41584-023-01053-w","volume":"20","author":"E Landy","year":"2023","unstructured":"Landy E, Carol H, Ring A, Canna S (2023) Biological and clinical roles of IL-18 in inflammatory diseases. Nat Rev Rheumatol 20(1):33\u201347. https:\/\/doi.org\/10.1038\/s41584-023-01053-w","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"2354_CR44","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/J.AJPATH.2024.12.011","volume":"195","author":"C Li","year":"2025","unstructured":"Li C, Fang Y, Chen YM (2025) Beyond redox regulation: novel roles of TXNIP in the pathogenesis and therapeutic targeting of kidney disease. Am J Pathol 195(4):615\u2013625. https:\/\/doi.org\/10.1016\/J.AJPATH.2024.12.011","journal-title":"Am J Pathol"},{"issue":"1","key":"2354_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/S12931-025-03369-5","volume":"26","author":"PY Lin","year":"2025","unstructured":"Lin PY, Lee KY, Ho SC, Chuang HC, Su BH, Wu YJ, Tseng PC, Tsai TT, Lin CF, Satria RD, Shih FC, Chen CL (2025) Oxidative stress triggers Itch-mediated TXNIP degradation and NF-\u03baB activation promoting chronic obstructive pulmonary disease. Respir Res 26(1):286. https:\/\/doi.org\/10.1186\/S12931-025-03369-5","journal-title":"Respir Res"},{"issue":"1","key":"2354_CR46","doi-asserted-by":"publisher","first-page":"1470380","DOI":"10.1155\/2021\/1470380","volume":"2021","author":"N Liu","year":"2021","unstructured":"Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H, Jiang J, Xu Y, Lu W (2021) The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev 2021(1):1470380. https:\/\/doi.org\/10.1155\/2021\/1470380","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"2354_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H, Tang L, Wang H, Xiang B, Chen P (2024) Pyroptosis in health and disease: mechanisms, regulation and clinical perspective. Signal Transduct Target Ther 9(1):245. https:\/\/doi.org\/10.1038\/s41392-024-01958-2","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"2354_CR48","doi-asserted-by":"publisher","first-page":"e70268","DOI":"10.1002\/MCO2.70268","volume":"6","author":"S Liu","year":"2025","unstructured":"Liu S, Liu J, Wang Y, Deng F, Deng Z (2025) Oxidative stress: signaling pathways, biological functions, and disease. MedComm 6(7):e70268. https:\/\/doi.org\/10.1002\/MCO2.70268","journal-title":"MedComm"},{"key":"2354_CR49","doi-asserted-by":"publisher","first-page":"100286","DOI":"10.1016\/J.ENDMTS.2025.100286","volume":"20","author":"R Liu","year":"2026","unstructured":"Liu R, Cao X, Fan Z, Tian Y, Li G, Shen Y, Guo LH, Zhang J, Qi Z (2026) Hyperglycemia aggravates cardiomyocyte oxidative stress via Caveolin-1\/Nrf2\/Keap1 signaling axis activation. Endocr Metab Sci 20:100286. https:\/\/doi.org\/10.1016\/J.ENDMTS.2025.100286","journal-title":"Endocr Metab Sci"},{"key":"2354_CR50","doi-asserted-by":"publisher","unstructured":"Ma J, Yang L, Ren J, Yang J (2018) Autophagy, oxidative stress, and redox regulation. In: Autophagy and cardiometabolic diseases: from molecular mechanisms to translational medicine, pp 237\u2013251. https:\/\/doi.org\/10.1016\/B978-0-12-805253-2.00020-1","DOI":"10.1016\/B978-0-12-805253-2.00020-1"},{"key":"2354_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2025.1595228\/FULL","author":"X Ma","year":"2025","unstructured":"Ma X, Zhang X (2025) Research progress of diabetic osteoporosis: a comprehensive review. Front Endocrinol. https:\/\/doi.org\/10.3389\/FENDO.2025.1595228\/FULL","journal-title":"Front Endocrinol"},{"key":"2354_CR52","doi-asserted-by":"publisher","unstructured":"Mahmoud A, Junejo R (2024) Oxidative stress in cardiovascular diseases. In: Biomarkers of oxidative stress: clinical aspects of oxidative stress, pp 45\u201370. https:\/\/doi.org\/10.1007\/978-3-031-69962-7_3\/SAVE-RESEARCH","DOI":"10.1007\/978-3-031-69962-7_3\/SAVE-RESEARCH"},{"issue":"13\u201315","key":"2354_CR53","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/15230864261421616;CTYPE:STRING:JOURNAL","volume":"44","author":"S Maimaiti","year":"2026","unstructured":"Maimaiti S, Dagnell M, Coppo L, Zhao W, Geserick P, Kappert K, Arn\u00e9r ESJ (2026) Thioredoxin 1 suppresses TXNIP-driven control of glucose metabolism in human cells. Antioxid Redox Signal 44(13\u201315):643\u2013660. https:\/\/doi.org\/10.1177\/15230864261421616;CTYPE:STRING:JOURNAL","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2354_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","volume":"22","author":"V Martinez Leon","year":"2025","unstructured":"Martinez Leon V, Hilburg R, Susztak K (2025) Mechanisms of diabetic kidney disease and established and emerging treatments. Nat Rev Endocrinol 22(1):21\u201335. https:\/\/doi.org\/10.1038\/s41574-025-01171-3","journal-title":"Nat Rev Endocrinol"},{"key":"2354_CR55","doi-asserted-by":"publisher","first-page":"1662037","DOI":"10.3389\/FENDO.2025.1662037\/TEXT","volume":"16","author":"KL Nelson","year":"2026","unstructured":"Nelson KL, Voruganti VS (2026) Implication of xanthine oxidoreductase in oxidative stress-related chronic diseases. Front Endocrinol 16:1662037. https:\/\/doi.org\/10.3389\/FENDO.2025.1662037\/TEXT","journal-title":"Front Endocrinol"},{"key":"2354_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/DIABETOLOGY6110140","author":"JP Netto","year":"2025","unstructured":"Netto JP, Pires VC, Castro MGM (2025) Diabetic bone disease: a comprehensive narrative review of pathophysiology, diagnosis, and evidence-based management. Diabetology. https:\/\/doi.org\/10.3390\/DIABETOLOGY6110140","journal-title":"Diabetology"},{"issue":"11","key":"2354_CR57","doi-asserted-by":"publisher","first-page":"e2121353119","DOI":"10.1073\/PNAS.2121353119","volume":"119","author":"U Ohto","year":"2022","unstructured":"Ohto U, Kamitsukasa Y, Ishida H, Zhang Z, Murakami K, Hirama C, Maekawa S, Shimizu T (2022) Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation. Proc Natl Acad Sci U S A 119(11):e2121353119. https:\/\/doi.org\/10.1073\/PNAS.2121353119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2354_CR58","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41423-025-01284-9","volume":"22","author":"S Paik","year":"2025","unstructured":"Paik S, Kim JK, Shin HJ, Park EJ, Kim IS, Jo EK (2025) Updated insights into the molecular networks for NLRP3 inflammasome activation. Cell Mol Immunol 22(6):563\u2013596. https:\/\/doi.org\/10.1038\/s41423-025-01284-9","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"2354_CR59","doi-asserted-by":"publisher","first-page":"7805115","DOI":"10.1155\/2022\/7805115","volume":"2022","author":"M Pan","year":"2022","unstructured":"Pan M, Zhang F, Qu K, Liu C, Zhang J (2022) TXNIP: a double-edged sword in disease and therapeutic outlook. Oxid Med Cell Longev 2022(1):7805115. https:\/\/doi.org\/10.1155\/2022\/7805115","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"2354_CR60","doi-asserted-by":"publisher","first-page":"7489795","DOI":"10.1155\/2020\/7489795","volume":"2020","author":"E Papachristoforou","year":"2020","unstructured":"Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K (2020) Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res 2020(1):7489795. https:\/\/doi.org\/10.1155\/2020\/7489795","journal-title":"J Diabetes Res"},{"key":"2354_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-981-96-9670-3_9","volume-title":"Basic understanding of oxidative stress and the pathophysiology of chronic diseases in human","author":"V Premnath","year":"2026","unstructured":"Premnath V, Veerappapillai S (2026) Basic understanding of oxidative stress and the pathophysiology of chronic diseases in human. Springer, pp 199\u2013218. https:\/\/doi.org\/10.1007\/978-981-96-9670-3_9"},{"issue":"1","key":"2354_CR62","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/S11033-026-12214-X","volume":"53","author":"F Qamar","year":"2026","unstructured":"Qamar F, Ahmad T, Vohora D, Sharma M (2026a) From sugar to flames: the detrimental role of pyroptosis in diabetes-associated bone loss. Mol Biol Rep 53(1):986. https:\/\/doi.org\/10.1007\/S11033-026-12214-X","journal-title":"Mol Biol Rep"},{"key":"2354_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/S11033-026-12214-X","author":"F Qamar","year":"2026","unstructured":"Qamar F, Ahmad T, Vohora D, Sharma M (2026b) From sugar to flames: the detrimental role of pyroptosis in diabetes-associated bone loss. Mol Biol Rep. https:\/\/doi.org\/10.1007\/S11033-026-12214-X","journal-title":"Mol Biol Rep"},{"issue":"5","key":"2354_CR64","doi-asserted-by":"publisher","first-page":"e70186","DOI":"10.1002\/DMRR.70186;PAGEGROUP:STRING:PUBLICATION","volume":"42","author":"F Qamar","year":"2026","unstructured":"Qamar F, Sharma M (2026) Beyond hyperglycaemia in diabetic bone disease: refining experimental models of diabetes-induced osteopathy. Diabetes Metab Res Rev 42(5):e70186. https:\/\/doi.org\/10.1002\/DMRR.70186;PAGEGROUP:STRING:PUBLICATION","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"2354_CR65","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1021\/ACS.JCIM.5C02172","volume":"66","author":"N Qayyum","year":"2026","unstructured":"Qayyum N, Khan AW, Haseeb M, Ahmed B, Farooq M, Manan A, Kim E, Choi S (2026) Generative AI uncovers novel Chrebp\/Txnip axis inhibitors with potential anti-inflammatory activity. J Chem Inf Model 66(8):4340\u20134364. https:\/\/doi.org\/10.1021\/ACS.JCIM.5C02172","journal-title":"J Chem Inf Model"},{"issue":"7","key":"2354_CR66","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/s12276-024-01261-8","volume":"56","author":"R Ramachandran","year":"2024","unstructured":"Ramachandran R, Manan A, Kim J, Choi S (2024) NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders. Exp Mol Med 56(7):1488\u20131500. https:\/\/doi.org\/10.1038\/s12276-024-01261-8","journal-title":"Exp Mol Med"},{"issue":"1","key":"2354_CR67","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000551943","volume":"33","author":"C Ramirez-Celis","year":"2026","unstructured":"Ramirez-Celis C, Mart\u00ednez-Torres AM, Mor\u00e1n J (2026) NLRP3 inflammasome activation in oxidative stress: a key mechanism driving neuroinflammation. NeuroImmunoModulation 33(1):236\u2013263. https:\/\/doi.org\/10.1159\/000551943","journal-title":"NeuroImmunoModulation"},{"key":"2354_CR68","doi-asserted-by":"publisher","first-page":"113172","DOI":"10.1016\/J.DIABRES.2026.113172","volume":"234","author":"FB Razi","year":"2026","unstructured":"Razi FB, Ashraf H, Singhal S, Qamar Z, Moin S (2026) Hyperglycaemia-induced metabolic stress and epigenetic imprinting in the inflammatory pathogenesis of diabetic neuropathy. Diabetes Res Clin Pract 234:113172. https:\/\/doi.org\/10.1016\/J.DIABRES.2026.113172","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2354_CR69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","volume":"25","author":"MJ Rodriguez-Colman","year":"2023","unstructured":"Rodriguez-Colman MJ, Dansen TB, Burgering BMT (2023) FOXO transcription factors as mediators of stress adaptation. Nat Rev Mol Cell Biol 25(1):46\u201364. https:\/\/doi.org\/10.1038\/s41580-023-00649-0","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2354_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/MEDSCI13030087","author":"B Roy","year":"2025","unstructured":"Roy B (2025) Pathophysiological mechanisms of diabetes-induced macrovascular and microvascular complications: the role of oxidative stress. Med Sci. https:\/\/doi.org\/10.3390\/MEDSCI13030087","journal-title":"Med Sci"},{"key":"2354_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX12040825","author":"R Rullo","year":"2023","unstructured":"Rullo R, Cerchia C, Nasso R, Romanelli V, Vendittis ED, Masullo M, Lavecchia A (2023) Novel reversible inhibitors of xanthine oxidase targeting the active site of the enzyme. Antioxidants. https:\/\/doi.org\/10.3390\/ANTIOX12040825","journal-title":"Antioxidants"},{"issue":"5","key":"2354_CR72","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1007\/S10787-024-01556-2","volume":"32","author":"A Satheesan","year":"2024","unstructured":"Satheesan A, Kumar J, Leela KV, Murugesan R, Chaithanya V, Angelin M (2024) Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications. Inflammopharmacology 32(5):2753\u20132779. https:\/\/doi.org\/10.1007\/S10787-024-01556-2","journal-title":"Inflammopharmacology"},{"issue":"3","key":"2354_CR73","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/J.SEMARTHRIT.2019.11.009","volume":"50","author":"N Schlesinger","year":"2020","unstructured":"Schlesinger N, Brunetti L (2020) Beyond urate lowering: analgesic and anti-inflammatory properties of allopurinol. Semin Arthritis Rheum 50(3):444\u2013450. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2019.11.009","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"2354_CR74","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-025-08059-0","volume":"16","author":"C S\u00e9tula","year":"2025","unstructured":"S\u00e9tula C, Pensado-Evans I, Scelza-Figueredo A, Orellano MS, Rodr\u00edguez-Valero I, Spinedi E, Mirmira RG, Andreone L, Perone MJ (2025) IL-1\u03b2 priming triggers an adaptive stress response that enhances pancreatic \u03b2-cell resilience to subsequent cytotoxic inflammatory insult. Cell Death Dis 16(1):744. https:\/\/doi.org\/10.1038\/s41419-025-08059-0","journal-title":"Cell Death Dis"},{"key":"2354_CR75","doi-asserted-by":"publisher","first-page":"100330","DOI":"10.1016\/J.METOP.2024.100330","volume":"24","author":"P Sharma","year":"2024","unstructured":"Sharma P, Sharma RK, Gaur K (2024) Understanding the impact of diabetes on bone health: a clinical review. Metab Open 24:100330. https:\/\/doi.org\/10.1016\/J.METOP.2024.100330","journal-title":"Metab Open"},{"issue":"3","key":"2354_CR76","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s12276-026-01656-9","volume":"58","author":"HJ Shin","year":"2026","unstructured":"Shin HJ, Kim IS, Kim JK, Jo EK (2026) Molecular mechanisms of NLRP3 inflammasome activation. Exp Mol Med 58(3):650\u2013663. https:\/\/doi.org\/10.1038\/s12276-026-01656-9","journal-title":"Exp Mol Med"},{"issue":"1","key":"2354_CR77","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/S11033-025-10490-7","volume":"52","author":"M Shyam","year":"2025","unstructured":"Shyam M, Sidharth S, Veronica A, Jagannathan L, Srirangan P, Radhakrishnan V, Sabina EP (2025) Diabetic retinopathy: a comprehensive review of pathophysiology and emerging treatments. Mol Biol Rep 52(1):380. https:\/\/doi.org\/10.1007\/S11033-025-10490-7","journal-title":"Mol Biol Rep"},{"key":"2354_CR78","doi-asserted-by":"publisher","DOI":"10.1177\/11795468241239542","author":"F Sosa","year":"2024","unstructured":"Sosa F, Shaban M, Lopez J, Duarte GJ, Jain S, Khizar A, Vittorio T, Mishra R, Rodriguez Guerra M (2024) Impact of hyperuricemia and urate-lowering agents on cardiovascular diseases. Clin Med Insights Cardiol. https:\/\/doi.org\/10.1177\/11795468241239542","journal-title":"Clin Med Insights Cardiol"},{"issue":"6","key":"2354_CR79","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/ARS.2011.4137","volume":"16","author":"ON Spindel","year":"2012","unstructured":"Spindel ON, World C, Berk BC (2012) Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid Redox Signal 16(6):587. https:\/\/doi.org\/10.1089\/ARS.2011.4137","journal-title":"Antioxid Redox Signal"},{"key":"2354_CR80","doi-asserted-by":"publisher","first-page":"156447","DOI":"10.1016\/J.PRP.2026.156447","volume":"282","author":"Y Su","year":"2026","unstructured":"Su Y, Zhou B, Yu C (2026) The TXNIP\/NLRP3 axis in coronary slow flow: redox-inflammatory mechanisms and pathological implications. Pathol Res Pract 282:156447. https:\/\/doi.org\/10.1016\/J.PRP.2026.156447","journal-title":"Pathol Res Pract"},{"key":"2354_CR81","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211062770","author":"S Suzuki","year":"2021","unstructured":"Suzuki S, Yoshihisa A, Yokokawa T, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Tsuda A, Tsuda T, Ishibashi T, Konno I, Yamaguchi O, Machii H, Nozaki N, Niizeki T, Miyamoto T, Takeishi Y (2021) Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial. J Int Med Res. https:\/\/doi.org\/10.1177\/03000605211062770","journal-title":"J Int Med Res"},{"key":"2354_CR82","unstructured":"Tandoc K (2019) The role of thioredoxin-interacting protein (TXNIP) in mediating the effects of phenformin and Torin1 on glucose uptake and cell proliferation"},{"key":"2354_CR83","doi-asserted-by":"publisher","first-page":"998574","DOI":"10.3389\/FPHAR.2022.998574\/FULL","volume":"13","author":"J Wan","year":"2022","unstructured":"Wan J, Liu D, Pan S, Zhou S, Liu Z (2022) NLRP3-mediated pyroptosis in diabetic nephropathy. Front Pharmacol 13:998574. https:\/\/doi.org\/10.3389\/FPHAR.2022.998574\/FULL","journal-title":"Front Pharmacol"},{"issue":"5","key":"2354_CR84","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41419-020-2598-6","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Shen X, Liu J, Chen W, Wu F, Wu W, Meng Z, Zhu M, Miao C (2020) High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression. Cell Death Dis 11(5):383. https:\/\/doi.org\/10.1038\/s41419-020-2598-6","journal-title":"Cell Death Dis"},{"issue":"2","key":"2354_CR85","doi-asserted-by":"publisher","first-page":"2300231","DOI":"10.1002\/ADTP.202300231","volume":"7","author":"R Wang","year":"2024","unstructured":"Wang R, Su S, Chen Z, Zhou F (2024) Type 2 diabetes mellitus mediated oxidative stress in bone tissues and novel challenges for biomaterials. Adv Ther 7(2):2300231. https:\/\/doi.org\/10.1002\/ADTP.202300231","journal-title":"Adv Ther"},{"key":"2354_CR86","doi-asserted-by":"publisher","first-page":"1749548","DOI":"10.3389\/FCVM.2026.1749548\/FULL","volume":"13","author":"Z Wang","year":"2026","unstructured":"Wang Z, Yang Y, Wang Q, Wang L, Zhao Y, Qian X, Feng R, Qian J (2026) Pathological mechanisms and clinical research progress of endothelial dysfunction. Front Cardiovasc Med 13:1749548. https:\/\/doi.org\/10.3389\/FCVM.2026.1749548\/FULL","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2354_CR87","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41413-026-00506-8","volume":"14","author":"Y Weng","year":"2026","unstructured":"Weng Y, Xiong J, Zhao Q, Tan Z (2026) HIF-1\u03b1 and BMAL1 in bone regeneration: crosstalk between hypoxia response and circadian rhythm. Bone Res 14(1):25. https:\/\/doi.org\/10.1038\/s41413-026-00506-8","journal-title":"Bone Res"},{"key":"2354_CR88","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/J.PREREP.2025.100027","volume":"3","author":"SA Wijdan","year":"2025","unstructured":"Wijdan SA, Bokhari SMNA, Alvares J, Latif V (2025) The role of interleukin-1 beta in inflammation and the potential of immune-targeted therapies. Pharmacol Res Rep 3:100027. https:\/\/doi.org\/10.1016\/J.PREREP.2025.100027","journal-title":"Pharmacol Res Rep"},{"key":"2354_CR89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/DMSO.S232221","volume":"13","author":"DZ Wondafrash","year":"2020","unstructured":"Wondafrash DZ, Nire\u2019a AT, Tafere GG, Desta DM, Berhe DA, Zewdie KA (2020) Thioredoxin-interacting protein as a novel potential therapeutic target in diabetes mellitus and its underlying complications. Diabetes Metabol Syndr Obes 13:43\u201351. https:\/\/doi.org\/10.2147\/DMSO.S232221","journal-title":"Diabetes Metabol Syndr Obes"},{"issue":"9","key":"2354_CR90","doi-asserted-by":"publisher","first-page":"e70351","DOI":"10.1002\/MCO2.70351","volume":"6","author":"X Xi","year":"2025","unstructured":"Xi X, Chen Q, Ma J, Wang X, Zhang Y, Xiong Q, Liu X, Xia Y, Li Y (2025) Glycolysis-histone lactylation crosstalk drives TXNIP\u2013NLRP3-mediated PANoptosome assembly and PANoptosis activation underlying diabetic retinopathy pathogenesis. MedComm 6(9):e70351. https:\/\/doi.org\/10.1002\/MCO2.70351","journal-title":"MedComm"},{"key":"2354_CR91","doi-asserted-by":"publisher","first-page":"112012","DOI":"10.1016\/J.MCE.2023.112012","volume":"577","author":"X Xi","year":"2023","unstructured":"Xi X, Wang M, Chen Q, Ma J, Zhang J, Li Y (2023) DNMT1 regulates miR-20a\/TXNIP-mediated pyroptosis of retinal pigment epithelial cells through DNA methylation. Mol Cell Endocrinol 577:112012. https:\/\/doi.org\/10.1016\/J.MCE.2023.112012","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2354_CR92","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X (2025) Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther 10(1):190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2354_CR93","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.3390\/IJMS24043807","volume":"24","author":"KJ Yang","year":"2023","unstructured":"Yang KJ, Choi WJ, Chang YK, Park CW, Kim SY, Hong YA (2023) Inhibition of xanthine oxidase protects against diabetic kidney disease through the amelioration of oxidative stress via VEGF\/VEGFR axis and NOX-FoxO3a-eNOS signaling pathway. Int J Mol Sci 24(4):3807. https:\/\/doi.org\/10.3390\/IJMS24043807","journal-title":"Int J Mol Sci"},{"key":"2354_CR94","doi-asserted-by":"publisher","first-page":"1359255","DOI":"10.3389\/FENDO.2024.1359255\/FULL","volume":"15","author":"DR Yang","year":"2024","unstructured":"Yang DR, Wang MY, Zhang CL, Wang Y (2024) Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol 15:1359255. https:\/\/doi.org\/10.3389\/FENDO.2024.1359255\/FULL","journal-title":"Front Endocrinol"},{"issue":"1","key":"2354_CR95","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","volume":"10","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zhao B, Wang Y, Lan H, Liu X, Hu Y, Cao P (2025) Diabetic neuropathy: cutting-edge research and future directions. Signal Transduct Target Ther 10(1):132. https:\/\/doi.org\/10.1038\/s41392-025-02175-1","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2354_CR96","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","volume":"9","author":"J Yao","year":"2024","unstructured":"Yao J, Sterling K, Wang Z, Zhang Y, Song W (2024) The role of inflammasomes in human diseases and their potential as therapeutic targets. Signal Transduct Target Ther 9(1):10. https:\/\/doi.org\/10.1038\/s41392-023-01687-y","journal-title":"Signal Transduct Target Ther"},{"key":"2354_CR97","doi-asserted-by":"publisher","DOI":"10.1007\/S40618-026-02894-4","author":"YH Yen","year":"2026","unstructured":"Yen YH, Wei JCC, Ko FS, Yen FS, Lin HJ, Li PY, Cho DY, Hwu CM, Hsu CC (2026) Microvascular complications and risk of osteoporosis and fractures in type 2 diabetes: a nationwide Asian cohort study. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/S40618-026-02894-4","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2354_CR98","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/ANTIOX9080765","volume":"9","author":"E Yoshihara","year":"2020","unstructured":"Yoshihara E (2020) TXNIP\/TBP-2: a master regulator for glucose homeostasis. Antioxidants 9(8):765. https:\/\/doi.org\/10.3390\/ANTIOX9080765","journal-title":"Antioxidants"},{"issue":"DEC","key":"2354_CR99","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/FIMMU.2013.00514","volume":"4","author":"E Yoshihara","year":"2014","unstructured":"Yoshihara E, Masaki S, Matsuo Y, Chen Z, Tian H, Yodoi J (2014) Thioredoxin\/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases. Front Immunol 4(DEC):514. https:\/\/doi.org\/10.3389\/FIMMU.2013.00514","journal-title":"Front Immunol"},{"key":"2354_CR100","doi-asserted-by":"publisher","first-page":"106990","DOI":"10.1016\/J.BIOCEL.2026.106990","volume":"199","author":"EE Yurdgulu","year":"2026","unstructured":"Yurdgulu EE, Ay YA, Bayir Y, Halici Z (2026) The vicious cycle of hyperglycemia and oxidative stress: novel mechanistic insights into a pathogenic alliance. Int J Biochem Cell Biol 199:106990. https:\/\/doi.org\/10.1016\/J.BIOCEL.2026.106990","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"2354_CR101","doi-asserted-by":"publisher","first-page":"e0192781","DOI":"10.1371\/JOURNAL.PONE.0192781","volume":"13","author":"S Zaj\u0105czkowski","year":"2018","unstructured":"Zaj\u0105czkowski S, Zi\u00f3\u0142kowski W, Badtke P, Zaj\u0105czkowski MA, Flis DJ, Figarski A, Smoli\u0144ska-Byla\u0144ska M, Wierzba TH (2018) Promising effects of xanthine oxidase inhibition by allopurinol on autonomic heart regulation estimated by heart rate variability (HRV) analysis in rats exposed to hypoxia and hyperoxia. PLoS ONE 13(2):e0192781. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0192781","journal-title":"PLoS ONE"},{"key":"2354_CR102","doi-asserted-by":"publisher","first-page":"101047","DOI":"10.1016\/J.REDOX.2018.11.005","volume":"25","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang L, Zhou L, Lei Y, Zhang Y, Huang C (2019) Redox signaling and unfolded protein response coordinate cell fate decisions under ER stress. Redox Biol 25:101047. https:\/\/doi.org\/10.1016\/J.REDOX.2018.11.005","journal-title":"Redox Biol"},{"key":"2354_CR103","doi-asserted-by":"publisher","first-page":"174368","DOI":"10.1016\/J.EJPHAR.2021.174368","volume":"908","author":"YS Zhang","year":"2021","unstructured":"Zhang YS, Lu LQ, Jiang YQ, Li NS, Luo XJ, Peng JW, Peng J (2021) Allopurinol attenuates oxidative injury in rat hearts suffered ischemia\/reperfusion via suppressing the xanthine oxidase\/vascular peroxidase 1 pathway. Eur J Pharmacol 908:174368. https:\/\/doi.org\/10.1016\/J.EJPHAR.2021.174368","journal-title":"Eur J Pharmacol"},{"issue":"18","key":"2354_CR104","doi-asserted-by":"publisher","first-page":"10632","DOI":"10.3390\/IJMS231810632","volume":"23","author":"L Zhang","year":"2022","unstructured":"Zhang L, Ai C, Bai M, Niu J, Zhang Z (2022) NLRP3 inflammasome\/pyroptosis: a key driving force in diabetic cardiomyopathy. Int J Mol Sci 23(18):10632. https:\/\/doi.org\/10.3390\/IJMS231810632","journal-title":"Int J Mol Sci"},{"key":"2354_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-023-44203-0","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Luo L, Xu X, Wu J, Wang F, Lu Y, Zhang N, Ding Y, Lu B, Zhao K (2023) Acetylation is required for full activation of the NLRP3 inflammasome. Nat Commun. https:\/\/doi.org\/10.1038\/S41467-023-44203-0","journal-title":"Nat Commun"},{"issue":"12","key":"2354_CR106","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/S00198-025-07636-5","volume":"36","author":"X Zhang","year":"2025","unstructured":"Zhang X, Xu D, Zhang R, Wang H, Yang G (2025) Interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling. Osteoporosis Int 36(12):2401\u20132409. https:\/\/doi.org\/10.1007\/S00198-025-07636-5","journal-title":"Osteoporosis Int"},{"key":"2354_CR107","doi-asserted-by":"publisher","first-page":"118499","DOI":"10.1016\/J.BIOPHA.2025.118499","volume":"191","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ni Q, Chen YP, Pei Z, Xu X (2025b) The molecular mechanisms of disulfidptosis and its role in diabetes mellitus and its complications. Biomed Pharmacother 191:118499. https:\/\/doi.org\/10.1016\/J.BIOPHA.2025.118499","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2354_CR108","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-025-02401-w","volume":"11","author":"L Zhao","year":"2026","unstructured":"Zhao L, Yuan J, Yang Q, Ma J, Yang F, Zou Y, Liu K, Liu F (2026) Diabetes and its complications: molecular mechanisms, prevention and treatment. Signal Transduct Target Ther 11(1):22. https:\/\/doi.org\/10.1038\/s41392-025-02401-w","journal-title":"Signal Transduct Target Ther"},{"key":"2354_CR109","doi-asserted-by":"publisher","first-page":"149978","DOI":"10.1016\/J.BBRC.2024.149978","volume":"717","author":"H Zhen","year":"2024","unstructured":"Zhen H, Hu Y, Liu X, Fan G, Zhao S (2024) The protease caspase-1: activation pathways and functions. Biochem Biophys Res Commun 717:149978. https:\/\/doi.org\/10.1016\/J.BBRC.2024.149978","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2354_CR110","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-024-01801-8","volume":"9","author":"C Zhu","year":"2024","unstructured":"Zhu C, Xu S, Jiang R, Yu Y, Bian J, Zou Z (2024) The gasdermin family: emerging therapeutic targets in diseases. Signal Transduct Target Ther 9(1):87. https:\/\/doi.org\/10.1038\/s41392-024-01801-8","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"2354_CR111","doi-asserted-by":"publisher","first-page":"119823","DOI":"10.1016\/J.BBAMCR.2024.119823","volume":"1871","author":"BK Ziehr","year":"2024","unstructured":"Ziehr BK, MacDonald JA (2024) Regulation of NLRPs by reactive oxygen species: a story of crosstalk. Biochimica et Biophysica Acta (BBA) Mol Cell Res 1871(8):119823. https:\/\/doi.org\/10.1016\/J.BBAMCR.2024.119823","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Cell Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02354-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02354-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02354-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:14:07Z","timestamp":1788963247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02354-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":111,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2354"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02354-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"8 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}